covid-19 fda - Search News

Order byBest matchMost fresh

COVID-19, FDA

Top News

Overview

Impacts

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a monovalent JN.1 lineage, with a preference for the LP.8.1 variant.

· 5h

· 3d · on MSN

FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups

· 3d · on MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 21h

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Alaska Dispatch News · 20h

Opinion: The FDA’s new covid vaccine policy is clear as mud

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 15h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

12hon MSN

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine access, and medical ethics.

1don MSN

FDA to limit COVID-19 boosters for 'low risk' people under 65. What to know in Tennessee

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

USA Today4d

FDA sets new COVID booster guidelines for healthy adults under 65

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later ...